DSCSA for Manufacturers
Thank you for contacting us; we’ll be in touch shortly.
New FDA Guidance: Verification Systems for DSCSA
View a summary of the FDA's thoughts on the DSCSA verification requirements.
80 Must-Know Serialization Terms for U.S. Wholesale Distributors
Learn the language of wholesale distributor serialization to accelerate your compliance journey.
Serialization and Beyond: The Sharp Packaging Story
The mission of U.S. contract packager Sharp Packaging is to drive the convergence between the physical package and the digital data points as they…
As DSCSA Manufacturer Serialization Enforcement Begins, More Than 250 TraceLink Customers Are Live
As full FDA serialization enforcement begins on November 28, TraceLink has helped more than 250 manufacturing companies go live with serialization.
Burlington Drug Company Partners with TraceLink
Hear wholesale distributor Burlington discuss how DSCSA lot level requirements have changed their business and how TraceLink has helped.
FDA Issues Long-Awaited Grandfathering Guidance
Insights into the November 27, 2017, FDA draft guidance around grandfathering product under DSCSA.
Saleable Returns Verification: What You Need to Know About Enforcement Discretion
See why companies should move ahead with a saleable returns solution even with FDA enforcement discretion.
DSCSA Serialization: Why Start Now?
To meet the DSCSA serialization deadline, pharmaceutical manufacturers must start preparing. Hear about compliance challenges.
FDA Issues Guidance on DSCSA Waivers, Exceptions and Exemptions
In May 2018, the FDA published new DSCSA guidance.
DSCSA and the Path to Digital Transformation in the Pharmacy
Investing in serialization for DSCSA compliance can transform your pharmacy operations. Find out more about digital transformation.
6 Common Saleable Returns Myths for Wholesalers
See the most common misconceptions about DSCSA Saleable Returns Verification—and why wholesalers can’t afford to wait to implement a solution.
FDA Announces Enforcement Delay for Manufacturers But Law Still in Effect
Understand what the announcement means for pharma companies as the November 2017 deadline approaches.